TRENTINI, FRANCESCA
TRENTINI, FRANCESCA
Dipartimento di Medicina e Chirurgia
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
2021-01-01 Mazzaschi, G.; Scandino, R.; Milanese, G.; Pavone, C.; Maurizio, B.; Silva, M.; Ledda, R.; Minari, R.; Trentini, F.; Buti, S.; Bordi, P.; Leonetti, A.; Quaini, F.; Sverzellati, N.; Romanel, A.; Tiseo, M.
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients
2021-01-01 Mazzaschi, G.; Milanese, G.; Moron Dalla Tor, L.; Leo, L.; Balbi, M.; Trentini, F.; Manini, M.; Pavone, C.; Silva, M.; Ledda, R. E.; Minari, R.; Bordi, P.; Buti, S.; Leonetti, A.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors
2022-01-01 Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients
2022-01-01 Buti, Sebastiano; Trentini, Francesca; Sepe, Pierangela; Claps, Melanie; Isella, Luca; Verzoni, Elena; Procopio, Giuseppe
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens
2022-01-01 Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS
2022-01-01 Mazzaschi, G; Moron Dalla Tor, L; Balbi, M; Milanese, G; Leo, L; Dalla Valle, B; Trentini, F; Lorusso, B; Verzè, M; Pluchino, M; Minari, R; Perrone, F; Bordi, P; Leonetti, A; Buti, S; Silva, M; Roti, G; Sverzellati, N; Quaini, F; Tiseo, M
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients
2021-01-01 Trentini, F.; Mazzaschi, G.; Milanese, G.; Pavone, C.; Madeddu, D.; Gnetti, L.; Frati, C.; Lorusso, B.; Lagrasta, C. A. M.; Minari, R.; Ampollini, L.; Ledda, R. E.; Silva, M.; Sverzellati, N.; Quaini, F.; Roti, G.; Tiseo, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy | 1-gen-2021 | Mazzaschi, G.; Scandino, R.; Milanese, G.; Pavone, C.; Maurizio, B.; Silva, M.; Ledda, R.; Minari, R.; Trentini, F.; Buti, S.; Bordi, P.; Leonetti, A.; Quaini, F.; Sverzellati, N.; Romanel, A.; Tiseo, M. | |
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients | 1-gen-2021 | Mazzaschi, G.; Milanese, G.; Moron Dalla Tor, L.; Leo, L.; Balbi, M.; Trentini, F.; Manini, M.; Pavone, C.; Silva, M.; Ledda, R. E.; Minari, R.; Bordi, P.; Buti, S.; Leonetti, A.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors | 1-gen-2022 | Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients | 1-gen-2022 | Buti, Sebastiano; Trentini, Francesca; Sepe, Pierangela; Claps, Melanie; Isella, Luca; Verzoni, Elena; Procopio, Giuseppe | |
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens | 1-gen-2022 | Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M | |
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS | 1-gen-2022 | Mazzaschi, G; Moron Dalla Tor, L; Balbi, M; Milanese, G; Leo, L; Dalla Valle, B; Trentini, F; Lorusso, B; Verzè, M; Pluchino, M; Minari, R; Perrone, F; Bordi, P; Leonetti, A; Buti, S; Silva, M; Roti, G; Sverzellati, N; Quaini, F; Tiseo, M | |
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients | 1-gen-2021 | Trentini, F.; Mazzaschi, G.; Milanese, G.; Pavone, C.; Madeddu, D.; Gnetti, L.; Frati, C.; Lorusso, B.; Lagrasta, C. A. M.; Minari, R.; Ampollini, L.; Ledda, R. E.; Silva, M.; Sverzellati, N.; Quaini, F.; Roti, G.; Tiseo, M. |